WHWK Aadi Bioscience Inc: Company Short-Term Debts

Symbol and logo of brand Aadi Bio (WHWK)

Aadi Bioscience Inc (WHWK) management is focused on autonomous survival and the search for a strategic buyer. Monitoring short-term liabilities visualizes the results of this policy, where the value of 0.00 records the metric level. Aadi Bioscience Inc (WHWK) is developing a unique therapy network for mTOR-dependent neoplasms using the drug Fyarro. However, global conflicts and patent disputes complicate foreign drug registration and raw material logistics.

WHWK aadibio.com Company Short-Term Loans and Borrowings (03/21/2025 - 10/29/2026)

WHWK (Aadi Bioscience, Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Aadi Bio|WHWK - Consensus Target
- company stock capitalization data:
Market Capitalization Aadi Bioscience Inc|WHWK - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Aadi Bioscience|WHWK - Accounting Value of Company|Market Cap to Net Assets Ratio aadibio.com|WHWK - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Aadi Bioscience Inc|WHWK - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Aadi Bio|WHWK - Company Aggregate Debts|Debt to Book Capitalization Ratio Aadi Bioscience Inc|WHWK - Company Long-Term Loans and Borrowings|Company Short-Term Debts Aadi Bioscience|Quick Ratio aadibio.com
- earnings and multiples data:
WHWK - Net Profit
Analysis of all company metrics:WHWK - aadibio.com
Manufactured products of Aadi Bioscience Inc

Aadi Bioscience Inc (WHWK) strategic alliances in the field of mTOR inhibitors require high liquidity to maintain the pace of clinical trials. An analysis of short-term borrowed capital allows for an assessment of the current debt load and management's ability to promptly refinance obligations amid subsidy volatility. This metric measures short-term financial stability, signaling to the investor the risks of cash shortages in the event of a sharp increase in accounts payable.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts CTOR|Company Short-Term Debts tuhurabio.com (HURA)|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Company Short-Term Debts Fate Therapeutics Inc FATE|TScan - Company Short-Term Debts|CSBR (Champions Oncology) - Company Short-Term Indebtedness|XBIT: Company Short-Term Debts|CVM - Short-Term Debt Volume|Company Current Liabilities OSTX|RADX: Company Short-Term Loans and Borrowings|Company Short-Term Debts ARTV|Company Short-Term Debt ANL (adlainortye.com)|Company Short-Term Debts VERU (Veru Inc.)|Short-Term Debt Volume tempesttx.com (TPST)|XLO - Company Short-Term Debt|Short-Term Debt Renovaro Inc.|muraloncology.com (MURA) - Company Short-Term Debt|KAPA - Short-Term Debt Volume|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Company Current Liabilities CytoMed (GDTC)|Company Short-Term Debts CRIS|Short-Term Debt Volume apollomicsinc.com|Company Short-Term Debts THAR (Tharimmune Corp)|Advanced Biomed Inc. (ADVB) - Short-Term Debt|GNPX - Company Short-Term Debt|CLDI (Calidi Biotherapeutics) - Company Short-Term Indebtedness|SBFM: Company Short-Term Debts|Company Current Liabilities Xenetic Biosciences, Inc.|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Current Liabilities AONC (American Oncology Network)|BGNE (beigene.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Short-Term Debt Volume Elevation Oncology Inc. (ELEV)|ICAD - Company Short-Term Debt|IKNA (Ikena Oncology, Inc.) - Company Short-Term Indebtedness|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Current Liabilities MOR|Company Current Liabilities NAYA Biosciences Inc (NAYA)|Company Short-Term Debts AAPGV